Abstract:BACKGROUND Peutz-Jeghers syndrome (PJS) is a rare hereditary neoplastic disorder mainly associated with serine/threonine kinase 11 (STK11 /LKB1 ) gene mutations. Preimplantation genetic testing can protect a patient's offspring from mutated genes; however, some variations in this gene have been interpreted as variants of uncertain significance (VUS), which complicate reproductive decision-making in genetic counseling. AIM To identify the pathogenicity of two missense variants and provide clinical guidance. METHODS Whole exome gene sequencing and Sanger sequencing were performed on the peripheral blood of patients with PJS treated at the Reproductive and Genetic Hospital of Citic-Xiangya. Software was employed to predict the protein structure, conservation, and pathogenicity of the two missense variation sites in patients with PJS. Additionally, plasmids were constructed and transfected into HeLa cells to observe cell growth. The differences in signal pathway expression between the variant group and the wild-type group were compared using western blot and immunohistochemistry. Statistical analysis was performed using one-way analysis of variance. P < 0.05 was considered statistically significant. RESULTS We identified two missense STK11 gene VUS [c.889A>G (p.Arg297Gly) and c.733C>T (p.Leu245Phe)] in 9 unrelated PJS families who were seeking reproductive assistance. The two missense VUS were located in the catalytic domain of serine/threonine kinase, which is a key structure of the liver kinase B1 (LKB1) protein. In vitro experiments showed that the phosphorylation levels of adenosine monophosphate-activated protein kinase (AMPK) at Thr172 and LKB1 at Ser428 were significantly higher in transfected variation-type cells than in wild-type cells. In addition, the two missense STK11 variants promoted the proliferation of HeLa cells. Subsequent immunohistochemical analysis showed that phosphorylated-AMPK (Thr172) expression was significantly lower in gastric, colonic, and uterine polyps from PJS patients with missense variations than in non-PJS patients. Our findings indicate that these two missense STK11 variants are likely pathogenic and inactivate the STK11 gene, causing it to lose its function of regulating downstream phosphorylated-AMPK (Thr172), which may lead to the development of PJS. The identification of the pathogenic mutations in these two clinically characterized PJS patients has been helpful in guiding them toward the most appropriate mode of pregnancy assistance. CONCLUSION These two missense variants can be interpreted as likely pathogenic variants that mediated the onset of PJS in the two patients. These findings not only offer insights for clinical decision-making, but also serve as a foundation for further research and reanalysis of missense VUS in rare diseases.

Mutation of STK11 gene in a family with Peutz-Jeghers syndrome

Mutations Analysis Ofstk 11 Gene in Chinese Families with Peutz-Jeghers Syndrome

Mutation Characteristic of STK_(11) Gene in Chinese with Peutz-Jeghers Syndrome

A De Novo Mutation of STK11 Gene in a Chinese Patient with Peutz–Jeghers Syndrome

Analysis of STK11 gene variant in five Chinese patients with Peutz-Jeghers syndrome

Novel and Recurrent Mutations of STK11 Gene in Six Chinese Cases with Peutz–Jeghers Syndrome

Clinical Characteristics and Stk11 Gene Mutations in Chinese Children with Peutz-Jeghers Syndrome

Clinical Characteristics And Genetic Analysis Of Gene Mutations In A Chinese Pedigree With Peutz-Jeghers Syndrome

A Clinical and Molecular Genetic Study in 11 Chinese Children With Peutz-Jeghers Syndrome.

Genetic variation at a splicing branch point in intron 7 of STK11: a rare variant decreasing its expression in a Chinese family with Peutz-Jeghers syndrome

Additional File 2: of the Altered Activity of P53 Signaling Pathway by STK11 Gene Mutations and Its Cancer Phenotype in Peutz-Jeghers Syndrome

The characteristics of gene mutations in Chinese patients with Charcot-Marie-Tooth disease]

[Spastin Gene Mutation in Chinese Patients with Hereditary Spastic Paraplegia].

Germline Mutations of the Lkb1 (stk11) Gene in Peutz-Jeghers Patients

Advance of Molecular Genetic Researches of Peutz-Jeghers Syndrome

Peutz-Jeghers syndrome without STK11 mutation may correlate with less severe clinical manifestations in Chinese patients

Two missense STK11 gene variations impaired LKB1/adenosine monophosphate-activated protein kinase signaling in Peutz-Jeghers syndrome

Must Peutz-Jeghers syndrome patients have the LKB1/STK11 gene mutation? A case report and review of the literature

Clinical and Molecular Analysis in Patients with Peutz-Jeghers Syndrome

P2.02-007 Molecular Spectrum of STK11 Gene Mutations in Patients with Non-Small-Cell Lung Cancer in Chinese Patients

Somatic STK11 mosaicism in a Turkish patient with Peutz-Jeghers syndrome